Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine

International Journal of Oncology

Volumn 27, Issue 4, 2005, Pages 1053-1059

  Colombo, Lucas L ^a   Vanzulli, Silvia I ^b   Villanueva, Angeles ^c   Cañete, Magdalena ^c   Juarranz, Angeles ^c   Stockert, Juan C ^c  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Cationic porphyrins; Mammary adenocarcinoma; Photodynamic therapy; Photosensitizing drugs; Repeated photodynamic treatments; Tumor regression

Indexed keywords

GLYCEROL; OXYGEN; PHOTOSENSITIZING AGENT; PORPHYRIN; TETRA(4 N METHYLPYRIDYL)PORPHINE; TETRA(4-N-METHYLPYRIDYL)PORPHINE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLEEDING; CANCER TRANSPLANTATION; CELL PROLIFERATION; CHEMICAL MODEL; CHEMISTRY; EXPERIMENTAL NEOPLASM; FEMALE; MALE; METABOLISM; METHODOLOGY; MOUSE; NECROSIS; PHOTOCHEMOTHERAPY; TIME;

ANIMALS; CELL PROLIFERATION; FEMALE; GLYCEROL; HEMORRHAGE; MALE; MAMMARY NEOPLASMS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MODELS, CHEMICAL; NECROSIS; NEOPLASM TRANSPLANTATION; OXYGEN; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; TIME FACTORS;

EID: 33644818085     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.27.4.1053     Document Type: Article

References (46)

1. Dougherty TJ: An update on photodynamic therapy applications. J Clin Laser Med Surg 20: 3-7, 2002.
2. Vrouenraets MB, Visser GW, Snow GB and van Dongen GA: Basic principles, applications in oncology and improved selectivity of photodynamic therapy. Anticancer Res 23: 505-522, 2003.
3. Spitzer M and Krumholz BA: Photodynamic therapy in gynecology. Obstet Gynecol Clin North Am 18: 649-659, 1991.
4. Jin M, Yang B, Zhang W and Wang Y: Photodynamic therapy for upper gastrointestinal tumours over the past 10 years. Semin Surg Oncol 10: 111-113, 1994.
5. Chang SC and Bown SG: Photodynamic therapy: applications in bladder cancer and other malignancies. J Formos Med Assoc 96: 853-863, 1997.
6. Ost D: Photodynamic therapy in lung cancer. Oncology 14: 379-386,2000.
7. Kalka K, Merk H and Mukhtar H: Photodynamic therapy in dermatology. J Am Acad Dermatol 42: 389-413, 2000.
8. Bressler NM and Bressler SB: Photodynamic therapy with Verteporfin (Visudyne): impact on ophthalmology and visual sciences. Invest Ophthalmol Vis Sci 41: 624-628, 2000.
9. Villanueva A, Vidania R, Stockert JC, Cañete M and Juarranz A: Photodynamic effects on cultured tumor cells. Cytoskeleton alterations and cell death mechanisms. In: Handbook of Photochemistry and Photobiology. Nalwa HS (ed.) American Scientific Publishers, California, pp79-117, 2003.
10. Almeida RD, Manadas BJ, Carvalho AP and Duarte CB: Intracellular signaling mechanisms in photodynamic therapy. Biochim Biophys Acta 1704: 59-86, 2004.
11. Stockert JC, Juarranz A, Villanueva A, Nonell S, Horobin RW, Soltermann AT, Durantini EN, Rivarola V, Colombo LL, Espada J and Cañete M: Photodynamic therapy: selective uptake of photosensitizing drugs into tumor cells. Curr Top Pharmacol 8: 185-217,2004.
12. Stockert JC, Juarranz A, Villanueva A and Cañete M: Photodynamic damage to HeLa cell microtubules induced by thiazine dyes. Cancer Chemother Pharmacol 39: 167-169, 1996.
13. Kandela IK, Bartlett JA and Indig GL: Effect of molecular structure on the selective phototoxicity of triarylmethane dyes toward tumor cells. Photochem Photobiol Sci 1: 309-314, 2002.
14. Sternberg ED, Dolphin D and Brückner C: Porphyrin-based photosensitizers for use in photodynamic therapy. Tetrahedron 54:4151-4202,1998.
15. Cañete M, Villanueva A, Domínguez V, Polo S, Juarranz A and Stockert JC: Meso-tetraphenylporphyrin: photosensitizing properties and cytotoxic effects on cultured tumor cells. Int J Oncol 13:497-504, 1998.
16. Villanueva A, Durantini EN, Stockert JC, Rello S, Vidania R, Cañete M, Juarranz A, Arranz R and Rivarola V: Photokilling of cultured tumour cells by the porphyrin derivative CF3. Anticancer Drug Des 16: 279-290, 2001.
17. Villanueva A, Domfnguez V, Polo S, Vendrell VD, Sanz C, Cañete M, Juarranz A and Stockert JC: Photokilling mechanisms induced by zinc(II)-phthalocyanine on cultured tumor cells. Oncol Res 11:447-453, 1999.
18. Strassert CA, Rodriguez ME, Fernández DA, Dicelio LE and Awruch J: Synthesis and properties of N-alkylsubstituted zinc (II) phthalocyanines as potential agents for photodynamic therapy. Curr Top Med Chem 3: 165-173, 2003.
19. Cañete M, Ortiz A, Juarranz A, Villanueva A, Nonell S, Borrell JI, Teixido J and Stockert JC: Photosensitizing properties of palladium- tetraphenylporphycene on cultured tumour cells. Anticancer Drug Des 15: 143-150,2000.
20. Cañete M, Ortega C, Gavaldá A, Cristobal J, Juarranz A, Nonell S, Teixido J, Borrell JI, Villanueva A, Rello S and Stockert JC: Necrotic cell death induced by photodynamic treatment of human lung adenocarcinoma A-549 cells with palladium(II)-tetraphenylporphycene. Int J Oncol 24: 1221-1228, 2004.
21. Verihac JB, Gaudemer A and Kraljic I: Water-soluble porphyrins and metalloporphyrins as photosensitizers in aerated aqueous solutions. I. Detection and determination of quantum yield of formation of singlet oxygen. Nouv J Chim 8: 401-406, 1984.
22. Villanueva A, Juarranz A, Diaz V, Gómez J and Cañete M: Photodynamic effects of a cationic meso-substituted porphyrin in cell cultures. Anticancer Drug Des 7: 297-303, 1992.
23. Juarranz A, Villanueva A, Díaz V and Cañete M: Photodynamic effects of the cationic porphyrin mejo-tetra(4-N-methylpyridyl) porphine, on microtubules of HeLa cells. J Photochem Photobiol B Biol 27: 47-53, 1995.
24. Fiel RJ: Porphyrin-nucleic acids interaction: a review. J Biomol Struct Dyn 6: 1259-1274, 1989.
25. Kruck NN, Dzhagarov BM, Galievsky VA, Chirvony VS and Turpin PY: Photophysics of the cationic 5,10,15,20-tetrakis (4-N-methylpyridyl) porphyrin bound to DNA, [poly (dA-dT)]2 and [poly (dG-dC)]2: interaction with molecular oxygen studied by porphyrin triplet-triplet absorption and singlet oxygen luminescence. J Photochem Photobiol B Biol 42: 181-190, 1998.
26. Villanueva A, Cañete M, Trigueros C, Rodríguez-Borlado L and Juarranz A: Photodynamic induction of DNA-protein crosslinking in solution by several sensitizers and visible light. Biopolymers 33: 239-244, 1993.
27. Shammas MA, Shmookler Reis RJ, Akiyama M, Koley H, Chauhan D, Hideshima T, Goyal RK, Hurley LH, Anderson KC and Munshi NC: Telomerase inhibition and cell growth arrest by G-quadruplex interactive agent in multiple myeloma. Mol Cancer Ther 2: 825-833, 2003.
28. Munson BR and Fiel RJ: DNA intercalation and photosensitization by cationic meso substituted porphyrins. Nucleic Acids Res 20: 1315-1319, 1992.
29. Smijs TGM, Nivard MJM and Schuitmaker HJ: Development of a test system for mutagenicity of photosensitizers using Drosophila melanogaster. Photochem Photobiol 79: 332-338, 2004.
30. Cernay T and Zimmermann HW: Selective photosensitization of mitochondria by the lipophilic cationic porphyrin POR10. J Photochem Photobiol B Biol 34: 191-196, 1996.
31. Villanueva A and Jori G: Pharmacokinetic and tumour-photosensitizing properties of the cationic porphyrin meso-tetra(4Nmethylpyridyl) porphine. Cancer Lett 73: 59-64, 1993.
32. Villanueva A, Caggiari L, Jori G and Milanesi C: Morphological aspects of an experimental tumour photosensitized with a mesosubstituted cationic porphyrin. J Photochem Photobiol B Biol 23: 49-56, 1994.
33. Urtreger AJ, Ladeda VE, Puricelli LI, Rivelli A, Vidal MC, Lustig ES and Bal de Kier Joffe ED: Modulation of fibronectin expression and proteolytic activity associated with the invasive and metastatic phenotype in two new murine mammary tumor cell lines. Int J Oncol 11: 489-496, 1997.
34. Oku N, Saito N, Namba Y, Tsukada H, Dolphin D and Okada S: Application of long-circulating liposomes to cancer photodynamic therapy. Biol Pharm Bull 20: 670-673, 1997.
35. Engbrecht BW, Menon C, Kachur AV, Hahn SM and Fraker DL: Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenografts model. Cancer Res 59: 4334-4342, 1999.
36. Kessel D, Woodburn K, Henderson BW and Chang CK: Sites of photodamage in vivo and in vitro by a cationic porphyrin. Photochem Photobiol 62: 875-881, 1995.
37. Jori G and Fabris C: Relative contributions of apoptosis and random necrosis in tumour response to photodynamic therapy: effect of the chemical structure of Zn(II)-phthalocyanines. J Photochem Photociol B Biol 43: 181-185, 1998.
38. Hu M, Brasseur N, Yildiz SZ, van Lier JE and Leznoff CC: Hydroxyphthalocyanines as potential photodynamic agents for cancer therapy. J Med Chem 41: 1789-1802, 1998.
39. Fabris C, Ometto C, Milanesi C, Jori G, Cook MJ and Russell DA: Tumour-localizing and tumour-photosensitizing properties of zinc(II)-octapentyl- phthalocyanine. J Photochem Photobiol B Biol 39: 279-284, 1997.
40. Wang ZJ, He YY, Huang CG, Huang JS, Huang YC, An JY, Gu Y and Jiang LJ: Pharmacokinetics, tissue distribution and photodynamic therapy efficacy of liposomal-delivered hypocrellin A, a potential photosensitizer för tumor therapy. Photochem Photobiol 70: 773-780, 1999.
41. 65Zn as a radiotracer. Br J Cancer 73: 49-53, 1996.
42. Agarwal R, Korman NJ, Mohan RR, Feyes DK, Jawed S, Zaim MT and Mukhtar H: Apoptosis is an early event during phthalocyanine photodynamic therapy-induced ablation of chemically induced squamous papillomas in mouse skin. Photochem Photobiol 63: 547-552, 1996.
43. Woodburn KW, Fan Q, Miles DR, Kessel D, Luo Y and Young SW: Localization and efficacy analysis of the phototherapeutic lutetium texaphyrin (PCI-0123) in the murine EMT6 sarcoma model. Photochem Photobiol 65: 410-415, 1997.
44. Evensen JF and Moan J: A test of different photosensitizers for photodynamic treatment of cancer in a murine tumor model. Photochem Photobiol 46: 859-865, 1987.
45. Peng Q, Moan J, Warloe T, Nesland JM and Rimington C: Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma. Int J Cancer 52: 433-443, 1992.
46. Jesionek A and Von Tappeiner H: Die Behandlung der Hautkarzinome mit fluoreszierenden Stoffen. Arch Klin Med 82: 72-76, 1905.